(Q40700534)

English

Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells.

scientific article published on May 2001

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

based on heuristic

inferred from title

0 references

DNA mismatch repair

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Grazia Graziani

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

I Portarena

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Bonmassar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Cell Death & Differentiation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

457-469

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Cell cycle control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

P53, cell cycle control and apoptosis: Implications for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Life without DNA repair

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Adenovirus‐mediated gene transfer of wild‐type p53 results in melanoma cell apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by adriamycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Polymerase delta variants in RER colorectal tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Mutation of a mutL homolog in hereditary colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Hypermutability and mismatch repair deficiency in RER+ tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

21 January 2018

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Eukaryotic mismatch repair: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of the mismatch repair system in temozolomide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400832

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CDD.4400832

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11423906%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40700534&oldid=2215864873"